SCHEMBL1760463

SCHEMBL1760463

COc1ccc(C(=O)Nc2ccc(CC[C@H]3COC(N)=N3)cc2)nc1.COc1ncccc1C(=O)Nc1ccc(CC[C@H]2COC(N)=N2)cc1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
NCOR2 Q9Y618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1759745 0.92
SCHEMBL1759748 0.92
SCHEMBL1760237 0.91
SCHEMBL1760233 0.91
SCHEMBL1759903 0.83
SCHEMBL1759906 0.83
SCHEMBL1759998 0.81 NPC1 (0.51)
SCHEMBL1760027 0.81 NPC1 (0.51)
SCHEMBL1759995 0.81 NPC1 (0.51)
SCHEMBL1760026 0.81 NPC1 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057973-A1 OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2011-05-19 WO claimed
WO-2011057973-A1 OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2011-05-19 WO disclosed